Oncotarget

Corrections:

Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis

PDF  |  How to cite

Oncotarget. 2018; 9:32273-32273. https://doi.org/10.18632/oncotarget.26009

Metrics: PDF 822 views  |   ?  

Ling Cao1,*, Yong-Jing Yang1,*, Jian-Dong Diao2, Xu-He Zhang1, Yan-Ling Liu1, Bo-Yu Wang1, Zhi-Wen Li3 and Shi-Xin Liu1

1 Department of Radiation Oncology, Cancer Hospital of Jilin Province, Changchun 130012, People’s Republic of China
2 Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun 130012, People’s Republic of China
3 Department of Anesthesiology, The First Hospital of Jilin University, Changchun, Jilin, 130021, People’s Republic of China
* These authors contributed equally to this work

Published: August 14, 2018

This article has been corrected: The correct affiliation is given below:

2 Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun 130012, People’s Republic of China

Original article: Oncotarget. 2017; 8:90308-90314. DOI: https://doi.org/10.18632/oncotarget.19856.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26009